Eupraxia Pharmaceuticals Email Formats

Biotechnology Research • Oak Bay, British Columbia, Canada • 21-50 Employees

Eupraxia Pharmaceuticals Email Formats

Eupraxia Pharmaceuticals uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@eupraxiapharmaceuticals.com), used 50% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@eupraxiapharmaceuticals.com	50%
{first name}{last name}	johndoe@eupraxiapharmaceuticals.com	50%

Key Contacts at Eupraxia Pharmaceuticals

Sylvain Lanouette

Director Of Medical Affairs

Natalia Zisman

Director Of Cmc

James Meikle

Director Of Corporate Development And Investor Relations

Siminder Bhatia

Senior Director Quality Assurance

Liam Macfarlane

Associate Director Of Research And Development

Susan Oakley

Associate Director

Christine Dobek

Associate Director Clinical Operations

Anastasia Litke

Associate Director Of Preclinical Research And Development

Company overview

Headquarters	Oak Bay, British Columbia, Canada
Phone number	+12505903968
Websites	eupraxiapharma.com eupraxiapharmaceuticals.com
SIC	283
Founded	2012
Employees	21-50
Socials

About Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals is a public, clinical-stage biotechnology company focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Diffusphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians are wanting to treat. We believe the potential for fewer adverse events may be achieved through the precision targeting and the stable and flat delivery of the active ingredient when using the Diffusphere™ technology, versus the peaks and troughs seen with more traditional drug delivery methods. The precision of Eupraxia's Diffusphere™ technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal disease, where Eupraxia currently is developing advanced treatments, to also be applicable in oncology, infectious disease and other critical disease areas.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Manager

Director

Entry

Employees by Department

Eupraxia Pharmaceuticals has 26 employees across 9 departments.

Departments

Number of employees

Funding Data

Eupraxia Pharmaceuticals has never raised funding before.

Frequently asked questions

Eupraxia Pharmaceuticals is located in Oak Bay, British Columbia, CA.

You can reach Eupraxia Pharmaceuticals at +12505903968.

Eupraxia Pharmaceuticals was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

Eupraxia Pharmaceuticals has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.